Oct. 20 (Bloomberg) -- The breakup of Abbott Laboratories into two companies will create a prescription-medicine spinoff that may become a $54 billion target for drugmakers looking to rejuvenate their flagging portfolios. ... Abbott Spinoff May Fetch $54 Billion as Humira Tempts Rivals
Wednesday, October 19, 2011
Abbott Spinoff May Fetch $54 Billion as Humira Tempts Rivals
Oct. 20 (Bloomberg) -- The breakup of Abbott Laboratories into two companies will create a prescription-medicine spinoff that may become a $54 billion target for drugmakers looking to rejuvenate their flagging portfolios. ... Abbott Spinoff May Fetch $54 Billion as Humira Tempts Rivals
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment